Skip to main content
SpringerLink
Log in

Impact of Infection on Transplant Outcomes: Transplant Infectious Disease Expertise as an Essential Component of Transplant Programs

  • Reference work entry
  • First Online:
Emerging Transplant Infections

  • 1117 Accesses

Abstract

Infectious complications are a major cause of morbidity and mortality in both solid organ and hematopoietic stem cell transplant patients. The risk of infection by common opportunistic pathogens like cytomegalovirus can be mitigated with the optimal use of molecular diagnostics and antiviral prophylaxis. Novel and emerging bacterial, viral, fungal, and parasitic pathogens may be more successfully managed with early diagnosis and therapy. In the care of solid organ and hematopoietic stem cell transplant candidates and recipients, involvement of physicians with expertise in transplant infectious diseases has been shown to improve outcomes. In addition to their essential role in decreasing patient morbidity and mortality, infectious disease specialists also add value to the transplant program through the development and implementation of infection prevention protocols. These specialists are on the front line of the response to new organisms that may present atypically or be difficult to recognize in patients receiving immunosuppressive therapies pre- and post-transplant. In this rapidly changing field, the Emerging Transplant Infections textbook provides updated information on the diagnosis, treatment, and prevention of significant infections often seen in this highly immunocompromised population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am J Transplant. 2004;4(3):384–9.

    Article  Google Scholar 

  2. Hamandi B, Husain S, Humar A, Papadimitropoulos EA. Impact of infectious disease consultation on the clinical and economic outcomes of solid organ transplant recipients admitted for infectious complications. Clin Infect Dis. 2014;59(8):1074–82.

    Article  Google Scholar 

  3. D’Souza A, Fretham C. Current uses and outcomes of hematopoietic stem cell transplantation (HCT): CIBMTR summary slides; 2018. https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx. Accessed 14 Aug 2020.

  4. Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, et al. Characteristics of late fatal infections after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2019;25(2):362–8.

    Article  Google Scholar 

  5. Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60(10):1451–61.

    Article  Google Scholar 

  6. Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123(7):631–7.

    Article  Google Scholar 

  7. Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect. 2006;12(4):345–52.

    Article  CAS  Google Scholar 

  8. Lahey T, Shah R, Gittzus J, Schwartzman J, Kirkland K. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine. 2009;88(5):263–7.

    Article  Google Scholar 

  9. Nagao M, Iinuma Y, Saito T, Matsumura Y, Shirano M, Matsushima A, et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2010;16(12):1783–8.

    Article  CAS  Google Scholar 

  10. Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C, Wagner D, Hubner J, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation – a study of 521 patients in Germany. J Infect. 2009;59(4):232–9.

    Article  Google Scholar 

  11. Robinson JO, Pozzi-Langhi S, Phillips M, Pearson JC, Christiansen KJ, Coombs GW, et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis. 2012;31(9):2421–8.

    Article  CAS  Google Scholar 

  12. Tissot F, Calandra T, Prod’hom G, Taffe P, Zanetti G, Greub G, et al. Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality. J Infect. 2014;69(3):226–34.

    Article  CAS  Google Scholar 

  13. Farmakiotis D, Kyvernitakis A, Tarrand JJ, Kontoyiannis DP. Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation. Clin Microbiol Infect. 2015;21(1):79–86.

    Article  Google Scholar 

  14. Ishikane M, Hayakawa K, Kutsuna S, Takeshita N, Ohmagari N. The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years. PLoS One. 2019;14(4):e0215996.

    Article  CAS  Google Scholar 

  15. Viale P, Tedeschi S, Scudeller L, Attard L, Badia L, Bartoletti M, et al. Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department. Clin Infect Dis. 2017;65(8):1253–9.

    Article  Google Scholar 

  16. Schmitt S, McQuillen DP, Nahass R, Martinelli L, Rubin M, Schwebke K, et al. Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis. 2014;58(1):22–8.

    Article  Google Scholar 

  17. Brouqui P, Jouve E, Romain F, Sambuc R, Raoult D. Are infectious disease doctors better at caring for infectious diseases than other specialists? Clin Infect Dis. 2014;58(10):1486–7.

    Article  Google Scholar 

  18. McQuillen DP, MacIntyre AT. The value that infectious diseases physicians bring to the healthcare system. J Infect Dis. 2017;216(Suppl 5):S588–S93.

    Article  Google Scholar 

  19. Seo SK, Lo K, Abbo LM. Current state of antimicrobial stewardship at solid organ and hematopoietic cell transplant centers in the United States. Infect Control Hosp Epidemiol. 2016;37(10):1195–200.

    Article  Google Scholar 

  20. Kalil AC, Syed A, Rupp ME, Chambers H, Vargas L, Maskin A, et al. Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? A matched case-control propensity-adjusted study. Clin Infect Dis. 2015;60(2):216–22.

    Article  CAS  Google Scholar 

  21. Bahr NC, Beaudoin A, Drekonja D. Rapid access to comprehensive care may explain better outcomes in persons with sepsis with solid organ transplant versus those without solid organ transplant. Clin Infect Dis. 2015;60(12):1869–70.

    Article  Google Scholar 

  22. Forsblom E, Ruotsalainen E, Ollgren J, Jarvinen A. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;56(4):527–35.

    Article  CAS  Google Scholar 

  23. Harrison J, Hossain MA, Morsy M, Ghazanfar A. Outpatient parenteral antibiotic therapy in a renal transplant population: a single-center experience. Saudi J Kidney Dis Transpl. 2015;26(6):1121–9.

    Article  Google Scholar 

  24. Strymish J, Gupte G, Afable MK, Gupta K, Kim EJ, Vimalananda V, et al. Electronic consultations (e-consults): advancing infectious disease care in a large veterans affairs healthcare system. Clin Infect Dis. 2017;64(8):1123–5.

    Article  Google Scholar 

  25. McQuillen DP, Schmitt SK. Declare the past, diagnose the present, foretell the future: electronic consultations in infectious disease practice. Clin Infect Dis. 2017;64(8):1126–8.

    Article  Google Scholar 

  26. Vimalananda VG, Gupte G, Seraj SM, Orlander J, Berlowitz D, Fincke BG, et al. Electronic consultations (e-consults) to improve access to specialty care: a systematic review and narrative synthesis. J Telemed Telecare. 2015;21(6):323–30.

    Article  Google Scholar 

  27. Rieg S, Kupper MF. Impact of an infectious diseases consultation service on the quality of care and the survival of patients with infectious diseases. Z Evid Fortbild Qual Gesundhwes. 2015;109(7):500–10.

    Article  Google Scholar 

  28. Centers for Medicare & Medicaid Services (CMS), HHS. Requirements for approval and re-approval of transplant centers to perform organ transplants. Fed Regist. 2007;42:CFR parts 405, 482, 488, and 498(15205).

    Google Scholar 

  29. IDCOP. Fellowship training opportunities in transplant infectious diseases. American Society of Transplantations (AST) website. 2019. https://www.myast.org/communities-practice/infectious-disease/fellowship-training-opportunities-transplant-infectious

  30. Avery R, Clauss H, Danziger-Isakov L, Davis J, Doucette K, van Duin D, et al. Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation infectious diseases Community of Practice Educational Initiatives Working Group. Transpl Infect Dis. 2010;12(3):190–4.

    Article  CAS  Google Scholar 

  31. Cannas G, Pautas C, Raffoux E, Quesnel B, de Botton S, de Revel T, et al. Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial. Leuk Lymphoma. 2012;53(6):1068–76.

    Article  CAS  Google Scholar 

  32. Mulanovich V, Kontoyiannis DP. Acute myeloid leukemia and the infectious diseases consultant. Leuk Lymphoma. 2018;59(6):1284–91.

    Article  Google Scholar 

  33. Pongas G, Hamilos G, Rolston KV, Kontoyiannis DP. Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998–2008): diverse and impactful. Support Care Cancer. 2012;20(2):261–5.

    Article  CAS  Google Scholar 

  34. Granwehr BP, Kontoyiannis DP. The impact of infectious diseases consultation on oncology practice. Curr Opin Oncol. 2013;25(4):353–9.

    Article  Google Scholar 

  35. Kasper AK, Pallotta AM, Kovacs CS, Spinner ML. Infectious diseases consult improves vaccination adherence in kidney transplant candidates. Vaccine. 2018;36(34):5112–5.

    Article  CAS  Google Scholar 

  36. Ariza-Heredia EJ, Kontoyiannis DP. Our recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers. Mycoses. 2014;57(6):336–41.

    PubMed  Google Scholar 

  37. Schaenman JM, Kumar D, Kotton CN, Danziger-Isakov L, Morris MI. Transplant center support for infectious diseases. Transpl Infect Dis. 2017;19(5). https://doi.org/10.1111/tid.12746.

  38. Special issue – Transplant infectious diseases clinical transplantation: Wiley online library. 2019. https://onlinelibrary.wiley.com/journal/13990012

Download references

Author information

Authors and Affiliations

  1. Immunocompromised Host Service, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA

    Michele I. Morris

Authors
  1. Michele I. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michele I. Morris .

Editor information

Editors and Affiliations

  1. Immunocompromised Host Service Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA

    Michele I. Morris

  2. Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Camille Nelson Kotton

  3. Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA

    Cameron R. Wolfe

Section Editor information

  1. Duke University, Durham, NC, USA

    Cameron R. Wolfe

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Morris, M.I. (2021). Impact of Infection on Transplant Outcomes: Transplant Infectious Disease Expertise as an Essential Component of Transplant Programs. In: Morris, M.I., Kotton, C.N., Wolfe, C.R. (eds) Emerging Transplant Infections. Springer, Cham. https://doi.org/10.1007/978-3-030-25869-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25869-6_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25868-9

  • Online ISBN: 978-3-030-25869-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation